Acute post-operative pain and gut microbiota; is there any (clinical) relationship?
Journal of Cellular & Molecular Anesthesia,
Vol. 2 No. 4 (2017),
11 December 2017
,
Page 189-193
https://doi.org/10.22037/jcma.v2i4.19180
Abstract
Gut microbiota are the primary focus for a number of active research fields; one of their main areas of effect seem to be their effects on acute pain. Though it is generally realized that development of gut microbiota is after birth, the initial microbial core originates from maternal microbiota in fetus life, rapidly colonizing to adulthood microflora in 3-5 years. Understanding the crosstalk between microbiota, changes in gut flora and post-operative pain, and recognizing the underlying mechanisms are novel fields of study.
- Postoperative Pain
- Gut Microbiota
- maternal microbiota
- fetus
How to Cite
References
Rodriguez JM, Murphy K, Stanton C, Ross RP, Kober OI, Juge N, et al. The composition of the gut microbiota throughout life, with an emphasis on early life. Microb Ecol Health Dis. 2015;26:26050.
Thursby E, Juge N. Introduction to the human gut microbiota. Biochem J. 2017;474(11):1823-36.
Correa-Oliveira R, Fachi JL, Vieira A, Sato FT, Vinolo MA. Regulation of immune cell function by short-chain fatty acids. Clin Transl Immunology. 2016;5(4):e73.
Morrison DJ, Preston T. Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism. Gut microbes. 2016;7(3):189-200.
Maslowski KM, Vieira AT, Ng A, Kranich J, Sierro F, Yu D, et al. Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature. 2009;461(7268):1282-6.
Macfarlane S, Macfarlane GT. Regulation of short-chain fatty acid production. Proc Nutr Soc. 2003;62(1):67-72.
Lyte M. Microbial endocrinology in the microbiome-gut-brain axis: how bacterial production and utilization of neurochemicals influence behavior. PLoS Pathog. 2013;9(11):e1003726.
Sharon G, Garg N, Debelius J, Knight R, Dorrestein PC, Mazmanian SK. Specialized metabolites from the microbiome in health and disease. Cell metabolism. 2014;20(5):719-30.
Williams MR, Stedtfeld RD, Tiedje JM, Hashsham SA. MicroRNAs-Based Inter-Domain Communication between the Host and Members of the Gut Microbiome. Frontiers in microbiology. 2017;8:1896.
Liu S, da Cunha AP, Rezende RM, Cialic R, Wei Z, Bry L, et al. The Host Shapes the Gut Microbiota via Fecal MicroRNA. Cell Host Microbe. 2016;19(1):32-43.
Kreth S, Hubner M, Hinske LC. MicroRNAs as Clinical Biomarkers and Therapeutic Tools in Perioperative Medicine. Anesth Analg. 2017.
Neudecker V, Brodsky KS, Kreth S, Ginde AA, Eltzschig HK. Emerging Roles for MicroRNAs in Perioperative Medicine. Anesthesiology. 2016;124(2):489-506.
Filip AT, Balacescu O, Marian C, Anghel A. Microbiota Small RNAs in Inflammatory Bowel Disease. Journal of gastrointestinal and liver diseases : JGLD. 2016;25(4):509-16.
Ley RE, Backhed F, Turnbaugh P, Lozupone CA, Knight RD, Gordon JI. Obesity alters gut microbial ecology. Proc Natl Acad Sci U S A. 2005;102(31):11070-5.
Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 2006;444(7122):1027-31.
De Filippo C, Cavalieri D, Di Paola M, Ramazzotti M, Poullet JB, Massart S, et al. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci U S A. 2010;107(33):14691-6.
Devkota S, Wang Y, Musch MW, Leone V, Fehlner-Peach H, Nadimpalli A, et al. Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-/- mice. Nature. 2012;487(7405):104-8.
Lutgendorff F, Akkermans LM, Soderholm JD. The role of microbiota and probiotics in stress-induced gastro-intestinal damage. Curr Mol Med. 2008;8(4):282-98.
Lange K, Buerger M, Stallmach A, Bruns T. Effects of Antibiotics on Gut Microbiota. Dig Dis. 2016;34(3):260-8.
de Vrese M, Schrezenmeir J. Probiotics, prebiotics, and synbiotics. Adv Biochem Eng Biotechnol. 2008;111:1-66.
Shimizu K, Ogura H, Asahara T, Nomoto K, Morotomi M, Tasaki O, et al. Probiotic/synbiotic therapy for treating critically ill patients from a gut microbiota perspective. Dig Dis Sci. 2013;58(1):23-32.
Jalanka J, Salonen A, Salojarvi J, Ritari J, Immonen O, Marciani L, et al. Effects of bowel cleansing on the intestinal microbiota. Gut. 2015;64(10):1562-8.
Million M, Diallo A, Raoult D. Gut microbiota and malnutrition. Microb Pathog. 2017;106:127-38.
Mack I, Cuntz U, Gramer C, Niedermaier S, Pohl C, Schwiertz A, et al. Weight gain in anorexia nervosa does not ameliorate the faecal microbiota, branched chain fatty acid profiles, and gastrointestinal complaints. Scientific reports. 2016;6:26752.
Komatsu S, Yokoyama Y, Nagino M. Gut microbiota and bacterial translocation in digestive surgery: the impact of probiotics. Langenbecks Arch Surg. 2017;402(3):401-16.
SM OM, Dinan TG, Cryan JF. The gut microbiota as a key regulator of visceral pain. Pain. 2017;158 Suppl 1:S19-S28.
Luczynski P, Tramullas M, Viola M, Shanahan F, Clarke G, O'Mahony S, et al. Microbiota regulates visceral pain in the mouse. Elife. 2017;6.
Crouzet L, Gaultier E, Del'Homme C, Cartier C, Delmas E, Dapoigny M, et al. The hypersensitivity to colonic distension of IBS patients can be transferred to rats through their fecal microbiota. Neurogastroenterol Motil. 2013;25(4):e272-82.
Vieira AT, Macia L, Galvao I, Martins FS, Canesso MC, Amaral FA, et al. A Role for Gut Microbiota and the Metabolite-Sensing Receptor GPR43 in a Murine Model of Gout. Arthritis & rheumatology (Hoboken, NJ). 2015;67(6):1646-56.
Russo R, Cristiano C, Avagliano C, De Caro C, La Rana G, Raso GM, et al. Gut-brain axis: Role of lipids in the regulation of inflammation, pain and CNS diseases. Current medicinal chemistry. 2017.
Martin CR, Mayer EA. Gut-Brain Axis and Behavior. Nestle Nutrition Institute workshop series. 2017;88:45-53.
Li XS, Obeid S, Klingenberg R, Gencer B, Mach F, Raber L, et al. Gut microbiota-dependent trimethylamine N-oxide in acute coronary syndromes: a prognostic marker for incident cardiovascular events beyond traditional risk factors. European heart journal. 2017;38(11):814-24.
Heimesaat MM, Karadas G, Alutis M, Fischer A, Kuhl AA, Breithaupt A, et al. Survey of small intestinal and systemic immune responses following murine Arcobacter butzleri infection. Gut pathogens. 2015;7:28.
Gauguet S, D'Ortona S, Ahnger-Pier K, Duan B, Surana NK, Lu R, et al. Intestinal Microbiota of Mice Influences Resistance to Staphylococcus aureus Pneumonia. Infection and immunity. 2015;83(10):4003-14.
Cocciolillo S, Collins SM. The long-term functional consequences of acute infectious diarrhea. Current opinion in gastroenterology. 2016;32(1):1-6.
Barnes D, Yeh AM. Bugs and Guts: Practical Applications of Probiotics for Gastrointestinal Disorders in Children. Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition. 2015;30(6):747-59.
Benzon HT, Anderson TA. Themed Issue on the Opioid Epidemic: What Have We Learned? Where Do We Go From Here? Anesth Analg. 2017;125(5):1435-7.
Meng H, Johnston B, Englesakis M, Moulin DE, Bhatia A. Selective Cannabinoids for Chronic Neuropathic Pain: A Systematic Review and Meta-analysis. Anesth Analg. 2017;125(5):1638-52.
Nathan N. Unraveling the Mystery of THC: Cannabinoids and Neuropathic Pain. Anesth Analg. 2017;125(5):1428.
Knezevic NN, Yekkirala A, Yaksh TL. Basic/Translational Development of Forthcoming Opioid- and Nonopioid-Targeted Pain Therapeutics. Anesth Analg. 2017;125(5):1714-32.
Wanderer JP, Nathan N. Molecular Targets for Pain Management: More Than Just Mu. Anesth Analg. 2017;125(5):1427.
McKernan DP, Fitzgerald P, Dinan TG, Cryan JF. The probiotic Bifidobacterium infantis 35624 displays visceral antinociceptive effects in the rat. Neurogastroenterol Motil. 2010;22(9):1029-35, e268.
Ait-Belgnaoui A, Han W, Lamine F, Eutamene H, Fioramonti J, Bueno L, et al. Lactobacillus farciminis treatment suppresses stress induced visceral hypersensitivity: a possible action through interaction with epithelial cell cytoskeleton contraction. Gut. 2006;55(8):1090-4.
Ringel-Kulka T, Goldsmith JR, Carroll IM, Barros SP, Palsson O, Jobin C, et al. Lactobacillus acidophilus NCFM affects colonic mucosal opioid receptor expression in patients with functional abdominal pain - a randomised clinical study. Aliment Pharmacol Ther. 2014;40(2):200-7.
- Abstract Viewed: 559 times
- PDF Downloaded: 347 times